Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

INTRODUCTION: While adjuvant therapy of early-stage non-small-cell lung cancer (NSCLC) is widely accepted, literature data concerning neoadjuvant treatment provide contradictory results with both improved and unaffected survival rates. Also, data concerning potential effects of neo-adjuvant therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chorostowska-Wynimko, J, Zaleska, J, Chabowski, M, Szpechcinski, A, Zych, J, Rudzinski, P, Langfort, R, Orlowski, T, Roszkowski-Sliz, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521347/
https://www.ncbi.nlm.nih.gov/pubmed/20156723
http://dx.doi.org/10.1186/2047-783X-14-S4-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521347/
https://www.ncbi.nlm.nih.gov/pubmed/20156723
http://dx.doi.org/10.1186/2047-783X-14-S4-42

Ejemplares similares